UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | F | G | H | J | K | L | M | P | R | S | T
Number of items: 51.

A

Almassy, R; Bowman, K; Calvert, AH; Curtin, NJ; Golding, BT; Hostomska, Z; ... Webber, S; + view all (1998) 2-phenylbenzimidazole-4-carboxamides are potent inhibitors of the DNA repair enzyme poly(ADP-ribose)-polymerase (PARP). Annals of Oncology , 9 116 - ?.

B

Bhatia, J; Pedley, RB; Sharma, SK; Boxer, GM; Read, DA; Boden, RW; ... Begent, RHJ; + view all (1998) A distribution study at sub-millimetre resolution of a recombinant MFE-23:CPG(2) fusion protein in a colorectal cancer xenograft model. British Journal of Cancer , 78 147 - 147.

Bhatia, J; Pedley, RB; Sharma, SK; Boxer, GM; Read, DA; Michael, P; ... R, HJ; + view all (1998) A distribution study at sub-millimetre resolution of a recombinant MFE:CPG2 fusion protein in a colorectal cancer xenograft model. In: (Proceedings) Proceedings BACR, Br J Cancer. (pp. 61 - ?).

Bhhhhhatia, J; Pedley, RB; Sharma, SK; Boxer, GM; Read, DA; Boden, RW; ... Begent, RHJ; + view all (1998) A distribution study at sub-millimetre resolution of a recombinant MFE-23:CPG(2) fusion protein in a colorectal cancer xenograft model. In: (Proceedings) British Journal of Cancer. (pp. 147 - 147).

C

Caroline, R; (1998) My cancer and the magic bullet. UNSPECIFIED

Cooke, SP; Lawrence, L; Boxer, GM; Chester, KA; Begent, RHJ; (1998) Phage-derived single chain Fv antibody fragments to vascular endothelial cell growth factor. In: British Journal of Cancer. (pp. 91 - 91).

D

deKretser, D; Skakkebaek, NE; Wylie, CC; Harland, SJ; Oosterhuis, JW; (1998) Germ cell cancer and disorders of spermatogenesis: An environmental connection? Discussion. Apmis , 106 12 - 12.

Dische, S; Saunders, MI; (1998) Hypoxic cell radiosensitiation- clinical relevance in1998. In: Kogelnik, HD and Sedlmayer, E, (eds.) Progress in Radio-oncology VI. (205 - 223). Monduzzi

F

Flynn, AA; Green, AJ; Boxer, GM; Pedley, RB; Begent, RHJ; (1998) A dosimetry model for the accurate characterisation of absorbed doses in mouse organs. British Journal of Cancer , 78 60 - 60.

G

Geh, JI; Makris, A; Ashford, R; Grosch, E; GlynneJones, R; (1998) Preoperative chemoradiotherapy for locally advanced rectal cancer. British Journal of Cancer , 78 23 - 23.

Gibson, V; Anderson, RJ; Hartley, JA; Cairns, D; (1998) Synthesis of anthraquinone-oligodeoxynucleotide conjugates as inhibitors of gene transcription. Annals of Oncology , 9 101 - 101.

Goodchild, KA; Hill, SA; Chaplin, DJ; Hoskin, PJ; Saunders, MI; (1998) Modification of human tumour blood flow using pentoxifylline and carbogen. British Journal of Cancer , 78 45 - 45.

Grant, S; Boyle, F; Calvert, AH; Curtin, NJ; Endicott, J; Golding, BT; ... Robson, C; + view all (1998) O-6-alkylguanines as selective inhibitors of cyclin dependent kinases. Annals of Oncology , 9 523 - ?.

H

Harland, SJ; Linke, J; Kliesch, S; Looijenga, L; Dieckmann, KP; Grigor, K; ... Oosterhuis, JW; + view all (1998) The value of the biopsy of the contralateral testis in patients with testicular germ cell cancer: The recent German experience -Discussion. Apmis , 106 20 - 23.

Harland, SJ; Nicholson, PW; (1998) Implications of a hereditary model for testis cancer. In: Jones, WG and Appleyard, I and Harnden, P and Joffe, JK, (eds.) Germ Cell Tumours IV. (17 - 25). John Libbey & Co. Ltd.

Hoskin, PJ; (1998) Major advances in the management of metastatic bone pain. UNSPECIFIED

Hoskin, PJ; (1998) Palliativtherapie. In: Schmitt, G and Pape, H and Doker, RD, (eds.) Diagnostik und Interdisziplinare Therapie maligner Tumoren-Eine Einfuhrung fur Studierende und Arzte-Herausgeber. Unimed Verlag, Lorch/Bremen

Hoskin, PJ; Makin, W; (1998) Oncology for Palliative Medicine. Oxford University Press

Hoskin, PJ; Rembowska, A; (1998) Dosimetry rules for brachytherapy using high dose rate remote afterloading implants. CLIN ONCOL , 10 226 - 230.

Hoskin, PJ; Saunders, MI; Goodchild, K; Powell, MEB; Taylor, J; Baddeley, H; (1998) Dynamic contrast enhanced magnetic resonance scanning to predict outcome after radiotherapy for head & neck cancer. British Journal of Cancer , 78 15 - 15.

Hughes, AN; Griffin, MJ; Calvert, AH; Johnston, A; Kerr, B; Lee, C; ... Boddy, AV; + view all (1998) Pharmacokinetic interactions in a phase I study of nolatrexed (AG337, THYMITAQ (TM)) and paclitaxel in patients with advanced solid tumours. Annals of Oncology , 9 463 - ?.

J

Jackman, AL; Mitchell, F; Lynn, S; Aherne, GW; Rees, C; Calvert, AH; ... Smith, M; + view all (1998) Evidence for the duration of the antifolate action of the thymidylate synthase (TS) inhibitor ZD9331 using plasma dUrd as a surrogate marker of enzyme inhibition. Annals of Oncology , 9 604O - ?.

Jackson, H; Bacon, L; Pedley, RB; Derbyshire, E; Field, A; Osborn, JAA; D,; (1998) Antigen specificity and tumour targeting efficiency of a human CEA specific scFv and affinity matured derivatives. British Journal of Cancer , 78 181 - 188.

Jayson, GC; Middleton, M; Lee, SM; Ashcroft, L; Thatcher, N; (1998) A randomized phase II trial of interleukin 2 and interleukin 2-interferon alpha in advanced renal cancer. British Journal of Cancer , 78 (3) 366 - 369.

Judson, I; Maughan, T; Beale, P; Primrose, J; Hoskin, P; Hanwell, J; ... Sutcliffe, F; + view all (1998) Effects of impaired renal function on the pharmacokinetics of raltitrexed (Tomudex ZD1694). British Journal of Cancer , 78 1188 - 1193.

K

Kretser, D; Giwercman, A; Heidenreich, A; Oliver, RTD; Kliesch, S; Harland, SJ; Lauke, H; (1998) Gonadal function in men with testicular cancer: Biological and clinical aspects - Discussion. Apmis , 106 34 - 36.

L

Lee, SM; Radford, JA; Dobson, L; Huq, T; Ryder, WDJ; Pettengell, R; ... Crowther, D; + view all (1998) Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost. British Journal of Cancer , 77 (8) 1294 - 1299.

M

Makris, A; Powles, TJ; Ashley, SE; Chang, J; Hickish, T; Tidy, VA; ... Ford, HT; + view all (1998) A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Annals of Oncology , 9 1179 - 1184.

Makris, A; Powles, TJ; Titley, J; Trott, PA; Ormerod, MG; (1998) Evidence for metastases to a single axillary lymph node from two separate primary breast carcinomas. Breast , 7 173 - 176.

Marshman, E; Calvert, AH; Newell, DR; Curtin, NJ; (1998) Dipyridamole selectively potentiates antipurine antifolates in human tumour cell lines but not normal tissue targets of dose-limiting toxicity. Annals of Oncology , 9 589 - ?.

Middleton, MR; Lorigan, P; Lee, SM; Yip, D; Davies, J; Harper, P; Thatcher, N; (1998) Dacarbazine, BCNU, cisplatin and tamoxifen (DBCT) v dacarbazine and interferon (DTIC/Ifn) in advanced melanoma: results of a randomised phase lll study. In: (Proceedings) 1998 ASCO Annual Meeting/34th Annual Meeting, Los Angeles, CA.. (pp. 508a - ?). Proceedings of the American Society of Clinical Oncology

Middleton, MR; Lunn, JM; Morris, C; Rustin, G; Wedge, SR; Brampton, MH; ... Thatcher, N; + view all (1998) O-6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma. British Journal of Cancer , 78 (9) 1199 - 1202.

Mitchell, F; Lynn, S; Rees, C; Judson, I; Calvert, AH; Ratain, M; ... Jackman, AL; + view all (1998) Plasma 2 '-deoxyuridine (dUrd) as a surrogate marker of thymidylate synthase (TS) inhibition in patients in phase I clinical trials of the TS inhibitor ZD9331. Annals of Oncology , 9 614 - ?.

P

Page, D; Ekbom, A; Skakkebaek, NE; Rorth, M; Harland, SJ; Hardell, L; ... Vistisen, K; + view all (1998) Increasing incidence of testicular cancer - birth cohort effects - Discussion. Apmis , 106 229 - 231.

Pedley, RB; Sharma, SK; Boden, R; Boxer, GM; Springer, CJ; Begent, RHJ; (1998) Enhancement of adept with anti-vasculature drugs in a xenograft model. British Journal of Cancer , 78 106 - 106.

Pedley, RB; Sharma, SK; Boden, R; Boxer, GM; Springer, CJAB; R, HJ; (1998) Enhancement of ADEPT with anti-vascular drugs in a xenograft model. In: (Proceedings) Proceedings BACR, Br J Cancer. (pp. 51 - ?).

Pietersz, GA; Patrick, MR; Chester, KA; (1998) Preclinical characterization and in vivo imaging studies of an engineered recombinant technetium-99m-labeled metallothionein-containing anti-carcinoembryonic antigen single-chain antibody. Journal of Nuclear Medicine , 39 47 - 56.

Plummer, R; Calvert, AH; Judson, I; Beale, P; Rees, C; Gokal, S; ... Mayne, K; + view all (1998) Phase I trial of ZD9331 given as a 30 minute infusion on days 1 and 8 with cycles repeated every 3 weeks. Annals of Oncology , 9 617 - ?.

R

Rees, C; Beale, P; Plummer, R; Highley, M; Calvert, AH; Judson, I; ... Mayne, K; + view all (1998) Phase I trial of ZD9331 given as a 30 minute infusion on days 1 and 8 with cycles repeated every 3 weeks. Annals of Oncology , 9 628P - ?.

S

Saunders, MI; (1998) CHART: The results and the relevance to clinical practice. In: Kogelnik, HD and Sedlmayer, E, (eds.) Progress in Radio-Oncology VI. (753 - 767). Monduzzi

Shaaaaarma, SK; Bhatia, J; Pedley, RB; Read, DA; Michael, P; Boden, RW; ... Begent, RHJ; + view all (1998) Biodistribution of enzyme activity of a fusion protein for use in ADEPT. In: (Proceedings) British Journal of Cancer. (pp. 48 - 48).

Shah, N; Hoskin, P; Saunders, M; Novell, R; Makris, A; (1998) Low dose Folinic acid with bolus and infusional 5 Fluorouracil chemotherapy in advanced colorectal carcinomas. British Journal of Cancer , 78 62 - 62.

Sharma, SK; Bhatia, J; Pedley, RB; Read, DA; Michael, P; Boden, RW; ... Begent, RHJ; + view all (1998) Biodistribution of enzyme activity of a fusion protein for use in ADEPT. In: British Journal of Cancer. (pp. 48 - 48).

Sharma, SK; Bhatia, J; Pedley, RB; Read, DA; Michael, P; Boden, RW; ... Begent, RHJ; + view all (1998) Biodistribution of enzyme activity of a fusion protein for use in ADEPT. British Journal of Cancer , 78 48 - 48.

Sharma, SK; Bhatia, J; Pedley, RB; Read, DA; Michael, P; Chester, KAAB; R, HJ; (1998) In vivo enzyme activity of a fusion protein for use in ADEPT. In: (Proceedings) Proceedings Americal Association for Cancer Research. (pp. 277 - ?).

Short, S; (1998) UNSPECIFIED In: (Proceedings) Low dose effects.

Short, S; (1998) UNSPECIFIED In: (Proceedings) The British Institute of Radiology 'New ideas in fractionation'.

Short, S; C, J; M,; (1998) Cellular response to low-dose irradiation. Clinical Oncology , 10 73 - 78.

Singer, JM; Hartley, JM; Brennan, C; Nicholson, PW; Souhami, RL; (1998) The pharmacokinetics and metabolism of ifosfamide during bolus and infusional administration: a randomized cross-over study. British Journal of Cancer , 77 978 - 984.

Smith, PG; Newell, DR; Barnes, MJ; Calvert, AH; Curtin, NJ; (1998) Potentiation of the in vitro activity of the multi-targeted antifolate MTA (LY231514) by dipyridamole. Annals of Oncology , 9 588 - ?.

T

Thatcher, N; Lee, SM; Woll, PJ; Middleton, M; Anderson, H; Burt, P; Stout, R; (1998) Dose intensity in small cell lung cancer. Seminars in Oncology , 25 (2) 12 - 18.

This list was generated on Sun May 24 03:54:30 2015 BST.